Apoptosis Induced by Topoisomerase Inhibitors

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)


Volume 16, 12 Issues, 2016


Download PDF Flyer




Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Apoptosis Induced by Topoisomerase Inhibitors



Anti-Cancer Agents in Medicinal Chemistry, 3(4): 271-290.

Author(s): Olivier Sordet, Qasim A. Khan, Kurt W. Kohn and Yves Pommier.

Affiliation: Bldg. 37, Rm. 5068, NIH, Bethesda MD 20892-4255, USA.

Abstract

Topoisomerase inhibitors are among the most efficient inducers of apoptosis. The main pathways leading from topoisomerase-mediated DNA damage to cell death involve activation of caspases in the cytoplasm by proapoptotic molecules released from mitochondria. In some cells, apoptotic response also involves the death receptor Fas (APO-1 / CD95). The engagement of these apoptotic effector pathways is tightly controlled by upstream regulatory pathways that respond to DNA lesions-induced by topoisomerase inhibitors in cells undergoing apoptosis. These include the proapoptotic Chk2, c-Abl and SAPK / JNK pathways, the survival PI(3)kinase-Akt-dependent pathway and the transcription factors p53 and NF-κB. Initiation of cellular responses to DNA lesions-induced by topoisomerase inhibitors is ensured by the protein kinases DNA-PK, ATM and ATR, which bind to DNA breaks. These kinases commonly called “DNA sensors” mediate their effects (DNA repair, cell cycle arrest and / or apoptosis) by phosphorylating a large number of substrates, including several downstream kinases such as c-Abl and the checkpoint protein Chk2. c-Abl induces apoptosis by activating cell death pathways (e.g., SAPK, p53 and p73) and inhibiting cell survival pathways [e.g., PI(3)kinase]. The DNA-damage regulating kinase Chk2, in addition to its role in cell cycle arrest and / or DNA repair, can induce apoptosis by phosphorylation / activation of the promyelocytic leukemia (PML) protein and p53. Finally, we will review the recent observations that support a role for topoisomerases in chromatin fragmentation during the execution phase of apoptosis.

Keywords:

topoisomerase, apoptosis, c-abl, chk2.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 3
Issue Number: 4
First Page: 271
Last Page: 290
Page Count: 20
DOI: 10.2174/1568011033482378
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science